A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC)-Reference-Cited by-同舟云学术

A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC)

Published:2022-02 Issue:2 Volume:22 Page:103-114
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Means-Powell Julie A.,Mayer Ingrid A.,Ismail-Khan Roohi,Del Valle Luis^ORCID,Tonetti Debra,Abramson Vandana G.^ORCID,Sanders Melinda S.,Lush Richard M.,Sorrentino Claudia,Majumder Samarpan,Miele Lucio^ORCID

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update;Takebe;Nature Rev Clin Oncol,2015

2. Notch pathway: a journey from notching phenotypes to cancer immunotherapy;Monticone;Advances exp med biol,2021

3. Targeting notch in oncology: the path forward;Majumder;Nat Rev Drug Discov,2021

4. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells;Espinoza;Cancer letters,2013

5. Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition;Espinoza;OncoTargets therapy,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Furin, ADAM, and γ-secretase: Core regulatory targets in the Notch pathway and the therapeutic potential for breast cancer;Neoplasia;2024-11

2. Prognostic and predictive impact of NOTCH1 in early breast cancer;Breast Cancer Research and Treatment;2024-08-17

3. Crosstalk of methylation and tamoxifen in breast cancer (Review);Molecular Medicine Reports;2024-08-09

4. Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies;Cancers;2024-07-07

5. Notch‐Targeted Therapeutic in Colorectal Cancer by Notch1 Attenuation Via Tumor Microenvironment‐Responsive Cascade DNA Delivery;Advanced Healthcare Materials;2024-06-03